The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Open accessAbstract
BACKGROUND: Multiple sclerosis (MS) is an important problem both for people with the disease and for society. There is no cure, and alleviation of symptoms forms the cornerstone of care. Excessive fatigue that severely limits activity is experienced by at least two-thirds of the estimated 60,000 people with MS in the UK. OBJECTIVES: (1) To identify current treatments for fatigue in MS and their evidence-base. (2) To systematically review the evidence for those treatments that have been investigated in more than one rigorous study, in order to determine their effectiveness and cost-effectiveness. METHODS: The review was carried out in two stages: a formal scoping review (to assess the range of interventions used by people with MS), and a systematic review for treatments that had been identified as promising and that had been investigated in clinical trials (as identified in the scoping review). A systematic review of research on costs and cost-effectiveness of those interventions identified as promising was also performed. Electronic databases, including MEDLINE and EMBASE, were searched for the period 1991-June 1999 (scoping review) and 1966-December 1999 (systematic review). Reference lists from publications were also searched, and experts were contacted for any additional information not already identified. RESULTS: Interventions identified for the treatment of fatigue in MS (1) Behavioural advice. This is the main element of initial clinical management and no rigorous research of its effectiveness was identified. (2) Drugs (amantadine, pemoline, potassium-channel blockers and antidepressants). (3) Training, rehabilitation and devices (cooling vests and electromagnetic fields). (4) Alternative therapies (bee venom, cannabis, acupuncture/acupressure and yoga). Only two drugs, amantadine and pemoline, met the criteria for full systematic review. RESULTS - EFFECTIVENESS OF AMANTADINE: One parallel and three crossover trials were found, involving a total of 236 people with MS. All studies were open to bias. All studies showed a pattern in favour of amantadine compared with placebo, but there is considerable uncertainty about the validity and clinical significance of this finding. This pattern of benefit was considerably undermined when different assumptions were used in the sensitivity analysis. RESULTS - EFFECTIVENESS OF PEMOLINE: One parallel and one crossover trial were found involving a total of 126 people with MS. Both studies were open to bias. There was no overall tendency in favour of pemoline over placebo and an excess of reports of adverse effects with pemoline. RESULTS - HEALTH ECONOMIC ANALYSIS: The drug costs of amantadine and pemoline are modest (pound 200 and pound 80 per annum, respectively). No economic evaluations were identified in the systematic review, and available data were insufficient to allow modelling of cost-effectiveness in this rapid review. CONCLUSIONS: There is insufficient evidence to allow people with MS, clinicians or policy makers to make informed decisions on the appropriate use of the many treatments on offer. Only amantadine appears to have some proven ability to alleviate the fatigue in MS, though only a proportion of users will obtain benefit and then only some of these patients will benefit sufficiently to take the drug in the long term. CONCLUSIONS - RECOMMENDATIONS FOR RESEARCH: The frequency, severity and impact of fatigue, the poverty of available research, and the absence of any ongoing research, suggest that new research is an urgent priority. People with MS, clinicians and policy makers should work together to ensure that the evidence required is collected as quickly as possible by encouraging involvement in rigorous research. Research should not be restricted to the two drugs reviewed in depth in this report. All interventions identified in the scoping review (see above) should be considered, as should basic scientific research into the underlying mechanism of fatigue in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Development of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact Scale
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_1.s79 · Cited by 1,541
The impact of fatigue on patients with multiple sclerosis
Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100048691 · Cited by 1,025
Krupp, L. B., Alvarez, L. A., LaRocca, N. G., & Scheinberg, L. C. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520280085020 · Cited by 997
Cross-Over Trials in Clinical Research
(1994) · Technometrics · doi:10.1080/00401706.1994.10485798 · Cited by 763
Impact of aerobic training on fitness and quality of life in multiple sclerosis
Petajan, J. H., Gappmaier, E., White, A. T., Spencer, M. K., Mino, L., & Hicks, R. W. (1996) · Annals of Neurology · doi:10.1002/ana.410390405 · Cited by 757
Cited by
Fatigue in neurological disorders
Chaudhuri, A., & Behan, P. O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15794-2 · Cited by 1,297
Validation of the Fatigue Severity Scale in a Swiss Cohort
Valko, P. O., Bassetti, C. L., Bloch, K. E., Held, U., & Baumann, C. R. (2008) · Sleep · doi:10.1093/sleep/31.11.1601 · Cited by 681
Flachenecker, P., Kümpfel, T., Kallmann, B., Gottschalk, M., Grauer, O., Rieckmann, P., Trenkwalder, C., & Toyka, K. V. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms839oa · Cited by 634
Hobart, J., & Cano, S. (2009) · Health Technology Assessment · doi:10.3310/hta13120 · Cited by 621
Randomized controlled trial of yoga and exercise in multiple sclerosis
Oken, B. S., Kishiyama, S., Zajdel, D., Bourdette, D., Carlsen, J., Haas, M., Hugos, C., Kraemer, D. F., Lawrence, J., & Mass, M. (2004) · Neurology · doi:10.1212/01.wnl.0000129534.88602.5c · Cited by 593
Evaluation of diagnostic tests when there is no gold standard. A review of methods
Rutjes, A., Reitsma, J., Coomarasamy, A., Khan, K., & Bossuyt, P. (2007) · Health Technology Assessment · doi:10.3310/hta11500 · Cited by 524
Moher, D., Pham, B., Lawson, M., & Klassen, T. (2003) · Health Technology Assessment · doi:10.3310/hta7410 · Cited by 500
Origin of Fatigue in Multiple Sclerosis: Review of the Literature
Kos, D., Kerckhofs, E., Nagels, G., D'hooghe, M. B., & Ilsbroukx, S. (2008) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968306298934 · Cited by 397
Jones, J., Shepherd, J., Baxter, L., Gospodarevskaya, E., Hartwell, D., Harris, P., & Price, A. (2009) · Health Technology Assessment · doi:10.3310/hta13350 · Cited by 357
Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale
Learmonth, Y. C., Dlugonski, D., Pilutti, L. A., Sandroff, B. M., Klaren, R., & Motl, R. W. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.023 · Cited by 349
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
Feinstein, A., Freeman, J., & Lo, A. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70231-5 · Cited by 281
Self-monitoring of blood glucose in type 2 diabetes: systematic review
Clar, C., Barnard, K., Cummins, E., Royle, P., & Waugh, N. (2010) · Health Technology Assessment · doi:10.3310/hta14120 · Cited by 274
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review
Oliva Ramirez, A., Keenan, A., Kalau, O., Worthington, E., Cohen, L., & Singh, S. (2021) · BMC Neurology · doi:10.1186/s12883-021-02396-1 · Cited by 257
Moss-Morris, R., McCrone, P., Yardley, L., van Kessel, K., Wills, G., & Dennison, L. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2012.03.001 · Cited by 209
Harker, J., & Kleijnen, J. (2012) · International Journal of Evidence-Based Healthcare · doi:10.1111/j.1744-1609.2012.00290.x · Cited by 137
Little, P., Turner, S., Rumsby, K., Warner, G., Moore, M., Lowes, J., Smith, H., Hawke, C., Turner, D., Leydon, G., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13190 · Cited by 137
Telemedicine in dermatology: a randomised controlled trial
Bowns, I., Collins, K., Walters, S., & McDonagh, A. (2006) · Health Technology Assessment · doi:10.3310/hta10430 · Cited by 109
Effects of Yoga on Psychological Health in Older Adults
Bonura, K. B., & Tenenbaum, G. (2014) · Journal of Physical Activity and Health · doi:10.1123/jpah.2012-0365 · Cited by 102
Vitamin K to prevent fractures in older women: systematic review and economic evaluation
Stevenson, M., Lloyd-Jones, M., & Papaioannou, D. (2009) · Health Technology Assessment · doi:10.3310/hta13450 · Cited by 90
van den Akker, L. E., Beckerman, H., Collette, E. H., Twisk, J. W., Bleijenberg, G., Dekker, J., Knoop, H., de Groot, V., & TREFAMS-ACE Study Group (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517709361 · Cited by 80
Veauthier, C., Hasselmann, H., Gold, S. M., & Paul, F. (2016) · EPMA Journal · doi:10.1186/s13167-016-0073-3 · Cited by 71
Noonan, V. K., Cook, K. F., Bamer, A. M., Choi, S. W., Kim, J., & Amtmann, D. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0040-3 · Cited by 54
Bol, Y., Duits, A. A., Vertommen-Mertens, C. E. R., Hupperts, R. M. M., Romberg-Camps, M. J. L., Verhey, F. R. J., & Vlaeyen, J. W. S. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.11.011 · Cited by 28
Specific treatment of residual fatigue in depressed patients.
(2004) · PubMed Central · Cited by 23
Metadata
- Authors
- Brañas, Jordan, Fry-Smith, Burls, & Hyde
- Venue
- Health Technology Assessment
- Published
- 2000
- Volume
- 4
- Issue
- 27
- Pages
- 1-61
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1488603340
- Cited by
- 330
- References
- 59
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- Health Technology Assessment Programme (99/05/05)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.